Literature DB >> 26621522

Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).

Satoshi Matsusaka1, Atsushi Nashimoto2, Kazuhiro Nishikawa3, Akira Miki4, Hiroto Miwa5, Kazuya Yamaguchi6, Takaki Yoshikawa7, Atsushi Ochiai8, Satoshi Morita9, Takeshi Sano1, Yasuhiro Kodera10, Yoshihiro Kakeji11, Junichi Sakamoto12, Shigetoyo Saji12, Kazuhiro Yoshida13.   

Abstract

Entities:  

Year:  2016        PMID: 26621522      PMCID: PMC4969921          DOI: 10.1007/s10120-015-0576-y

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


× No keyword cloud information.

Erratum to: Gastric Cancer DOI 10.1007/s10120-015-0518-8

In the original publication of the article, the data “Time to recurrence (<18 vs. ≥18 years)” was incorrectly published in Figs. 2 and 3. It should actually read “Time to recurrence (<18 vs. ≥18 months)”.
  2 in total

1.  Clinical significance of β2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma.

Authors:  Kengo Takahashi; Kyoichi Kaira; Akira Shimizu; Taisuke Sato; Norifumi Takahashi; Hiroomi Ogawa; Daisuke Yoshinari; Takehiko Yokobori; Takayuki Asao; Izumi Takeyoshi; Tetsunari Oyama
Journal:  Tumour Biol       Date:  2016-08-03

Review 2.  The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.

Authors:  Yu-Ying Lei; Jin-Yu Huang; Qiong-Rui Zhao; Nan Jiang; Hui-Mian Xu; Zhen-Ning Wang; Hai-Qing Li; Shi-Bo Zhang; Zhe Sun
Journal:  World J Surg Oncol       Date:  2017-03-21       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.